Gyermekkori daganatok: vizsgálatok itt: Svédország
65 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Gothenburg, Lund, Stockholm, Uppsala
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 1/2. fázisTaking peopleCAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
- Where
- Huddinge, Uppsala
- Életkor
- 18 év and over
- People
- 18
- Run by
- Uppsala University
See details and how to joinNCT06002659 · EU 2024-511844-18-00 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Solna
- Életkor
- 12 év and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - 2. fázisTaking people177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
- Where
- Solna
- Életkor
- 18 hónap to 64 év
- People
- 24 worldwide
- Run by
- Jakob Stenman
See details and how to joinNCT04903899 · EU 2023-503684-42-00 - 2/3. fázisTaking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Goteborg, Huddinge, Lund
- People
- 1541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Gothenburg
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1/2. fázisTaking peopleA Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Where
- Gothenburg
- Életkor
- 1 hónap to 17 év
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00 - No phaseTaking peopleMet Non Small Cell Cancer Registry (MOMENT)
- Where
- Linköping
- People
- 700 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891 - 3. fázisTaking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Gothenburg, Linkoping, Lund, Solna, Umea, Uppsala
- Életkor
- 1 év to 64 év
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - 3. fázisTaking peopleFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
- Életkor
- 4 év and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - 3. fázisTaking peopleInternational study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- Where
- Gothenburg, Linkoping, Lund, Stockholm, Umea, Uppsala
- Életkor
- Up to 17 év
- People
- 137 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501454-11-00 - 3. fázisTaking peopleBiological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
- Where
- Solna
- Életkor
- 6 hónap and over
- People
- 433 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05476939 · EU 2023-506027-29-00 - 3. fázisTaking peopleInternational Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Where
- Goteborg, Gothenburg, Linkoping, Lund, Solna, Stockholm, Umea, Uppsala
- Életkor
- Up to 64 év
- People
- 1351 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501180-40-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Gothenburg, Linkoping, Lund, Stockholm, Umeå, Uppsala
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - No phaseTaking peopleImplementation of Teledermoscopy and Artificial Intelligence
- Where
- Lund
- Életkor
- 15 év and over
- People
- 8000
- Run by
- Region Skane
See details and how to joinNCT05033678 - 2. fázisTaking peopleAntiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Where
- Gothenburg, Huddinge, Linkoping, Lund, Umea, Uppsala
- Életkor
- Up to 19 év
- People
- 232 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01356290 · EU 2024-515626-92-00 - 1/2. fázisTaking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Stockholm
- Életkor
- 1 év to 17 év
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Gavle, Solna
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 1/2. fázisTaking peopleA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Gothenburg
- Életkor
- 1 hónap to 17 év
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - No phaseTaking peopleMolecular and Clinical Studies of Bone and Soft Tissue Tumors
- Where
- Stockholm
- People
- 50 000
- Run by
- Karolinska Institutet
See details and how to joinNCT07822204 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Gothenburg, Lund, Solna
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 3. fázisTaking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Gothenburg, Linkoping, Lund, Solna, Umea, Uppsala
- Életkor
- Up to 64 év
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 - No phaseTaking peopleSiblings to a Child With Cancer: Needs and Pre-loss Grief
- Where
- Stockholm
- Életkor
- 12 év to 24 év
- People
- 200
- Run by
- Ersta Sköndal University College
See details and how to joinNCT06854822 - 3. fázisTaking peopleAn international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
- Where
- Gothenburg, Linkoping, Lund, Stockholm, Umea, Uppsala
- Életkor
- Up to 17 év
- People
- 301 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501456-28-00 - 1/2. fázisTaking peoplePhase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE)
- Where
- Solna
- Életkor
- Up to 64 év
- People
- 34 worldwide
- Run by
- Universitaetsklinikum Heidelberg AöR
See details and how to join2024-516896-34-00